Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cutland

Showing results (111-120 of 173) with videos related to

Pageof 18
Sort By:
Msphere|January 28, 2021
The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next GenerationManish Sadarangani, Tobias Kollmann, Gordean Bjornson, et al.
Vaccine|November 2, 2024
Burden of Lassa fever disease in pregnant women and children and options for preventionManu Chaudhary, Clare L Cutland, Mercedes Bonet, et al.
Lancet (London, England)|October 23, 2009
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trialClare L Cutland, Shabir A Madhi, Elizabeth R Zell, et al.
Vaccine|January 13, 2006
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlersShabir A Madhi, Clare Cutland, Yuwei Zhu, et al.
The Lancet. Infectious Diseases|August 29, 2020
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trialShabir A Madhi, Eleonora Aml Mutsaerts, Alane Izu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers in South Africa: A Longitudinal Cohort StudyMarta C Nunes, Vicky L Baillie, Gaurav Kwatra, et al.
The Lancet. Respiratory Medicine|June 12, 2020
Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trialsSaad B Omer, Dayna R Clark, Shabir A Madhi, et al.
Vaccine|July 19, 2025
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding womenFlor M Munoz, Beate Kampmann, Andy Stergachis, et al.
Vaccine: X|April 18, 2022
Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration projectApoorva Sharan, Shubhashri Jahagirdar, Anke L Stuurman, et al.
Vaccine|July 25, 2016
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataJayani Pathirana, Flor M Muñoz, Victoria Abbing-Karahagopian, et al.
Pageof 18

Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
Msphere|January 28, 2021
The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next GenerationManish Sadarangani, Tobias Kollmann, Gordean Bjornson, et al.
Vaccine|November 2, 2024
Burden of Lassa fever disease in pregnant women and children and options for preventionManu Chaudhary, Clare L Cutland, Mercedes Bonet, et al.
Lancet (London, England)|October 23, 2009
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trialClare L Cutland, Shabir A Madhi, Elizabeth R Zell, et al.
Vaccine|January 13, 2006
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlersShabir A Madhi, Clare Cutland, Yuwei Zhu, et al.
The Lancet. Infectious Diseases|August 29, 2020
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trialShabir A Madhi, Eleonora Aml Mutsaerts, Alane Izu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers in South Africa: A Longitudinal Cohort StudyMarta C Nunes, Vicky L Baillie, Gaurav Kwatra, et al.
The Lancet. Respiratory Medicine|June 12, 2020
Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trialsSaad B Omer, Dayna R Clark, Shabir A Madhi, et al.
Vaccine|July 19, 2025
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding womenFlor M Munoz, Beate Kampmann, Andy Stergachis, et al.
Vaccine: X|April 18, 2022
Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration projectApoorva Sharan, Shubhashri Jahagirdar, Anke L Stuurman, et al.
Vaccine|July 25, 2016
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataJayani Pathirana, Flor M Muñoz, Victoria Abbing-Karahagopian, et al.
Pageof 18